Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Efficacy of Tildrakizumab in Difficult-to-treat Areas in Psoriasis - ZODIPSO Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05938361
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:16.345029+00:00
Published At
2025-09-24T00:00:00+00:00
Record Updated At
2025-09-24
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Psoriasis Palmaris", "Psoriasis Genital", "Psoriasis of Scalp", "Psoriasis Plantaris", "Psoriasis Nail"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-09-24"
protocolSection.identificationModule.nctId
"NCT05938361"
protocolSection.identificationModule.officialTitle
"Efficacy of Tildrakizumab in Difficult-to-treat Areas in Psoriasis - ZODIPSO Study"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Psoriasis Palmaris (protocolSection.conditionsModule.conditions)
  • Psoriasis Genital (protocolSection.conditionsModule.conditions)
  • Psoriasis of Scalp (protocolSection.conditionsModule.conditions)
  • Psoriasis Plantaris (protocolSection.conditionsModule.conditions)
  • Psoriasis Nail (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.